FDA Approves Benralizumab to Treat Pediatric Patients Aged 6 to 11 Years With Severe Asthma
Benralizumab was previously approved by the FDA in 2017 as an add-on maintenance therapy for patients 12 years and older.
Benralizumab was previously approved by the FDA in 2017 as an add-on maintenance therapy for patients 12 years and older.
Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis through ex vivo clustered regularly interspaced short palindromic repeats (CRISPR)–Ca…
At Asembia’s AXS24 Summit, a clinician discusses the pathophysiology and classification of pulmonary arterial hypertension.
HSSPs improve medication adherence and reduce total health care costs by directly managing medications for complex chronic conditions like cancer, diabetes, COPD and CHF.
Trastuzumab is indicated for adjuvant breast cancer, metastatic breast cancer, and gastric cancer.
Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.
Medusozoans are characterized by the presence of a medusa (jellyfish) stage as part of the life cycle. Despite being a prominent trait in medusozoan evolution,…
This systematic review to support a 2024 US Preventive Services Task Force Recommendation Statement summarizes published evidence on the benefits and harms of screening for…
At Asembia’s AXS24 Summit, a clinician discusses the pathophysiology and classification of pulmonary arterial hypertension.
Physicians are in high demand — here’s how to find your new role